News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
464,390 Results
Type
Article (51237)
Company Profile (99)
Press Release (413054)
Multimedia
Podcasts (31)
Webinars (10)
Section
Business (129363)
Career Advice (1494)
Deals (18790)
Drug Delivery (67)
Drug Development (60978)
Employer Resources (102)
FDA (9653)
Job Trends (10292)
News (218530)
Policy (17834)
Tag
Academia (2703)
Academic (1)
Accelerated approval (4)
Adcomms (11)
Allergies (61)
Alliances (36995)
ALS (85)
Alzheimer's disease (1292)
Antibody-drug conjugate (ADC) (109)
Approvals (9691)
Artificial intelligence (201)
Autoimmune disease (20)
Automation (10)
Bankruptcy (130)
Best Places to Work (8295)
BIOSECURE Act (11)
Biosimilars (56)
Biotechnology (67)
Bladder cancer (52)
Brain cancer (22)
Breast cancer (224)
Cancer (1883)
Cardiovascular disease (126)
Career advice (1237)
Career pathing (25)
CAR-T (150)
Cell therapy (376)
Cervical cancer (12)
Clinical research (48413)
Collaboration (736)
Company closure (1)
Compensation (170)
Complete response letters (9)
COVID-19 (2208)
CRISPR (37)
C-suite (190)
Cystic fibrosis (92)
Data (1879)
Decentralized trials (2)
Denatured (12)
Depression (31)
Diabetes (189)
Diagnostics (4564)
Digital health (12)
Diversity (4)
Diversity, equity & inclusion (26)
Drug discovery (105)
Drug pricing (62)
Drug shortages (12)
Duchenne muscular dystrophy (60)
Earnings (46317)
Editorial (26)
Employer branding (15)
Employer resources (89)
Events (60725)
Executive appointments (569)
FDA (10560)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (5)
Funding (594)
Gene editing (82)
Generative AI (19)
Gene therapy (231)
GLP-1 (500)
Government (2810)
Grass and pollen (3)
Guidances (55)
Healthcare (12905)
Huntington's disease (11)
IgA nephropathy (15)
Immunology and inflammation (75)
Indications (24)
Infectious disease (2310)
Inflammatory bowel disease (109)
Inflation Reduction Act (5)
Influenza (46)
Intellectual property (78)
Interviews (285)
IPO (8934)
IRA (31)
Job creations (2331)
Job search strategy (1064)
Kidney cancer (7)
Labor market (27)
Layoffs (314)
Leadership (10)
Legal (3133)
Liver cancer (47)
Lung cancer (256)
Lymphoma (128)
Machine learning (6)
Management (33)
Manufacturing (214)
MASH (56)
Medical device (7372)
Medtech (7375)
Mergers & acquisitions (10252)
Metabolic disorders (447)
Multiple sclerosis (87)
NASH (14)
Neurodegenerative disease (75)
Neuropsychiatric disorders (13)
Neuroscience (1750)
NextGen: Class of 2025 (4187)
Non-profit (4282)
Now hiring (33)
Obesity (207)
Opinion (177)
Ovarian cancer (69)
Pain (57)
Pancreatic cancer (62)
Parkinson's disease (127)
Partnered (19)
Patents (165)
Patient recruitment (87)
Peanut (32)
People (39320)
Pharmaceutical (28)
Pharmacy benefit managers (6)
Phase I (15951)
Phase II (21066)
Phase III (15539)
Pipeline (1046)
Policy (94)
Postmarket research (2043)
Preclinical (7681)
Press Release (65)
Prostate cancer (80)
Psychedelics (22)
Radiopharmaceuticals (189)
Rare diseases (279)
Real estate (4051)
Recruiting (41)
Regulatory (13367)
Reports (30)
Research institute (2543)
Resumes & cover letters (232)
Rett syndrome (3)
RNA editing (1)
RSV (26)
Schizophrenia (62)
Series A (107)
Series B (60)
Service/supplier (10)
Sickle cell disease (43)
Special edition (13)
Spinal muscular atrophy (130)
Sponsored (24)
Startups (2540)
Stomach cancer (5)
Supply chain (32)
Tariffs (21)
The Weekly (19)
Vaccines (560)
Venture capitalists (22)
Weight loss (112)
Women's health (15)
Worklife (11)
Date
Today (83)
Last 7 days (640)
Last 30 days (1815)
Last 365 days (23393)
2025 (7741)
2024 (25051)
2023 (28960)
2022 (39039)
2021 (41582)
2020 (38259)
2019 (31888)
2018 (24100)
2017 (22433)
2016 (21986)
2015 (25802)
2014 (19281)
2013 (16689)
2012 (16707)
2011 (17503)
2010 (16176)
Location
Africa (600)
Alabama (46)
Alaska (3)
Arizona (96)
Arkansas (6)
Asia (28627)
Australia (5396)
California (4358)
Canada (1405)
China (403)
Colorado (162)
Connecticut (200)
Delaware (89)
Europe (66541)
Florida (647)
Georgia (147)
Idaho (34)
Illinois (343)
India (23)
Indiana (224)
Iowa (8)
Japan (140)
Kansas (68)
Kentucky (18)
Louisiana (4)
Maine (21)
Maryland (601)
Massachusetts (3146)
Michigan (150)
Minnesota (226)
Mississippi (1)
Missouri (53)
Montana (22)
Nebraska (15)
Nevada (30)
New Hampshire (31)
New Jersey (1298)
New Mexico (27)
New York (1289)
North Carolina (747)
North Dakota (5)
Northern California (1929)
Ohio (153)
Oklahoma (8)
Oregon (16)
Pennsylvania (879)
Puerto Rico (4)
Rhode Island (20)
South America (700)
South Carolina (13)
South Dakota (1)
Southern California (1702)
Tennessee (51)
Texas (653)
United States (16123)
Utah (123)
Virginia (102)
Washington D.C. (49)
Washington State (429)
West Virginia (1)
Wisconsin (38)
464,390 Results for "multiple myeloma research foundation mmrf".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
The Multiple Myeloma Research Foundation (MMRF) Announces the First Patient Enrolled in its Horizon Clinical Trials Program to Accelerate the Identification of Optimal Treatment Strategies for Multiple Myeloma
December 5, 2024
·
3 min read
Business
Multiple Myeloma Research Foundation (MMRF) Presents New Data from Multiple Myeloma Research Programs at the 21st International Myeloma Society Annual Meeting
September 25, 2024
·
5 min read
Press Releases
Multiple Myeloma Research Foundation (MMRF) Announces New Publication on CoMMpass℠ Study in Nature Genetics Defining Distinct Subtypes of Multiple Myeloma and High-Risk Genetic Markers
August 19, 2024
·
4 min read
Pharm Country
The Multiple Myeloma Research Foundation Announces $21M Grant Program to Support Multicenter Translational Research Networks
The Multiple Myeloma Research Foundation announced the recipients of three $7 million MMRF Myeloma Accelerator Challenge Program Grants totaling $21 million.
November 2, 2023
·
5 min read
MMRF Research Programs Expand Understanding of the Biology of Multiple Myeloma and Patient-Reported Outcomes in New Data Featured at the 20th IMS Annual Meeting
The Multiple Myeloma Research Foundation (MMRF) today announced that findings from three studies based on analyses of its CoMMpass℠ and CureCloud℠ datasets
September 27, 2023
·
4 min read
Pharm Country
The Multiple Myeloma Research Foundation (MMRF) Names Stephanie Oestreich, Ph.D., MPA, as Managing Director of the Myeloma Investment Fund (MIF)
The Multiple Myeloma Research Foundation has announced the appointment of Stephanie Oestreich, Ph.D., MPA, as Managing Director of its venture philanthropy subsidiary, the Myeloma Investment Fund.
October 5, 2023
·
3 min read
Cancer
Reframing Multiple Myeloma: From Fatal to Chronic and Even Curable
Traditionally carrying a dire prognosis, the treatment paradigm for multiple myeloma is changing, with CAR T therapies, bispecifics and more contributing to multifaceted regimens unique to each patient’s needs.
January 21, 2025
·
8 min read
·
Kate Goodwin
Press Releases
Lynozyfic™ (linvoseltamab) Approved in the European Union for the Treatment of Relapsed/Refractory Multiple Myeloma
April 29, 2025
·
14 min read
Press Releases
Starton Therapeutics Presents Positive Data from Phase 1b Study Evaluating STAR-LLD for the Treatment of Relapsed/Refractory Multiple Myeloma at the American Association for Cancer Research (AACR) Annual Meeting 2025
April 25, 2025
·
4 min read
Press Releases
Predicta Biosciences Launches its First Molecular Diagnostic Product to Improve the Prognosis of Multiple Myeloma
April 30, 2025
·
3 min read
1 of 46,439
Next
